NCT04056793 is a NA clinical trial of Optimized birthing position in Birth; Prolonged, sponsored by Centre Hospitalier Universitaire Vaudois.

Who is sponsoring NCT04056793?

NCT04056793 is sponsored by Centre Hospitalier Universitaire Vaudois.

What drugs are being tested in NCT04056793?

Interventions in NCT04056793: Optimized birthing position.

What condition does NCT04056793 study?

NCT04056793 studies Birth; Prolonged.

Is NCT04056793 still recruiting?

NCT04056793 is currently completed. Last updated 16 February 2021.

Last reviewed 2021-02-16 · How we verify

NCT04056793

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acceptability Assessment of an Optimized Birthing Position

Completed NA Last updated 16 February 2021

What this trial tests

NA trial testing Optimized birthing position in Birth; Prolonged in 20 participants. Completed in 1 January 2020.

Timeline

6 August 2019

Primary endpoint
1 January 2020

1 January 2020

Quick facts

Lead sponsor	Centre Hospitalier Universitaire Vaudois
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	6 August 2019
Primary completion	1 January 2020
Estimated completion	1 January 2020
Sites	1 location across Switzerland

Drugs / interventions tested

Optimized birthing position

Conditions studied

Birth; Prolonged — all drugs for Birth; Prolonged →

Sponsor

Centre Hospitalier Universitaire Vaudois

Who can join

Eligibility, female only, with Birth; Prolonged. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This qualitative study evaluates the acceptability of positioning pregnant women in labour in an optimized position, which consists in the hyperflexion of the legs and the loss of the lumbar lordosis. Twenty patients in situation of dystocia will adopt the described position for a limited amount of time.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Assessing feasibility and maternal acceptability of a biomechanically-optimized supine birth position: A pilot study.
Bouille L, Sichitiu J, Favre J, Desseauve D. · · 2021 · PMID 34506580 · DOI 10.1371/journal.pone.0257285

Verify or expand the search:

Other Centre Hospitalier Universitaire Vaudois trials

Trials by the same sponsor.

NCT07427511 — SwissNeuroRehab - HDHI · NA · recruiting
NCT07263438 — Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a · Phase 2 · recruiting
NCT07139756 — Deciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic Hypotension · not yet recruiting
NCT07109388 — Comparison of Pericapsular Nerve Group (PENG) Block With a Combined Femoral, Sciatic, Lateral Femoral Cutaneous Nerve Bl · NA · not yet recruiting
NCT07268378 — Supervision of Clinicians in Oncology by Psycho-oncologists : Evaluation · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04056793 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Vaudois
Last refreshed: 16 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04056793.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing